 | Webcast Covidien plc at Bank of America Merrill Lynch Health Care Conference (Live) 05/16/12 at 8:00 p.m. ET |
| |||||||||
 |
|
| Recent News | More >> |
| Covidien Completes Acquisition of superDimension, Ltd. - 05/15/12 |
| DUBLIN--(BUSINESS WIRE)--May. 15, 2012-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for a... More >> |
|
| Covidien to Present at Bank of America Merrill Lynch Conference - 05/09/12 |
| MANSFIELD, Mass.--(BUSINESS WIRE)--May. 9, 2012-- Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Bank of America Merrill Lynch 2012 Health Care Conference in Las Vegas, NV, ... More >> |
|
| Covidien Introduces New Treatment for Drug-Resistant Hypertension - 05/08/12 |
| Company to Unveil Novel Renal Denervation System at EuroPCR “Live” Cases with New Irrigated RF Balloon Catheter for Treatment of Hypertension PARIS--(BUSINESS WIRE)--May. 8, 2012-- Covidien (NYSE... More >> |
|
| Covidien and GE Healthcare Form Five-Year Collaboration - 05/03/12 |
| Bringing Covidien measurement technologies to GE Healthcare patient monitoring helps enhance clinical decision-making BOULDER, Colo. & MILWAUKEE--(BUSINESS WIRE)--May. 3, 2012-- Covidien (NYSE: COV) and GE ... More >> |
|
| Covidien Completes Acquisition of Newport Medical Instruments, Inc. - 05/01/12 |
| DUBLIN--(BUSINESS WIRE)--May. 1, 2012-- Covidien plc (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced that it ha... More >> |
|
| Covidien to Present at Deutsche Bank Conference - 04/30/12 |
| MANSFIELD, Mass.--(BUSINESS WIRE)--Apr. 30, 2012-- Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Deutsche Bank 37th Annual Health Care Conference in Boston on Monday, May 7... More >> |
|
| Covidien Reports Second-Quarter Results - 04/27/12 |
| View PDF Net sales up 5%; Medical Devices sales up 7% Second-quarter diluted GAAP earnings per share from continuing operations were $1.01; excluding specified items, adjusted diluted earnings per share from continuing operations were $1.05,... More >> |
|
| Mallinckrodt, a Covidien company, Joins The Partnership at Drugfree.org in Supporting “Wake Up To Medicine Abuse” - 04/10/12 |
| ST. LOUIS--(BUSINESS WIRE)--Apr. 10, 2012-- Mallinckrodt, the pharmaceuticals business of Covidien (NYSE: COV), today joined The Partnership at Drugfree.org in supporting the “Wake Up to Medicine Abuse” campaign. The i... More >> |
|
| Covidien Announces Definitive Agreement to Acquire Oridion Systems Ltd. - 04/05/12 |
| DUBLIN--(BUSINESS WIRE)--Apr. 5, 2012-- Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced a definitive a... More >> |
|
| Covidien Prevails in Patent Action against Applied Medical Resources - 04/04/12 |
| MANSFIELD, Mass.--(BUSINESS WIRE)--Apr. 4, 2012-- Covidien (NYSE: COV), a leading global provider of healthcare products, announced that it has prevailed against Applied Medical Resources Corp. in a patent action befor... More >> |
|
|
| Upcoming Events | More >> |
| ||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
